SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is experiencing intense volatility as escalating geopolitical tensions in the Middle East, particularly threats to oil supply routes, fuel a sharp divide between dip-buyers and those predicting a significant market correction amidst concerns over market manipulation and global economic stability.

Battalion Oil Corp. engages in the acquisition, production, exploration, and development of liquids-rich oil and natural gas assets in the Delaware Basin. The company was founded in 1987 and is headquartered in Houston, TX.

Battalion Oil Corp - Ordinary Shares (New)

Battalion Oil (BATL) is experiencing a massive rally amid geopolitical tensions fueling a spike in crude oil prices, with the community actively discussing its low float, potential for a significant short squeeze, and comparing it to past explosive runners. While many anticipate further parabolic moves, others caution about the risk of a sharp correction.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SLS is trending with intense community speculation around the highly anticipated Phase 3 results for its GPS cancer treatment, driven by observations of extended patient survival and expectations of a potential trial halt for overwhelming efficacy. This fuels discussions of a major short squeeze and a lucrative buyout as the stock pushes to establish a new floor above $5, attracting institutional interest and offering a potential safe haven in a volatile market.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is experiencing extreme volatility amid escalating Middle East tensions, with investors keenly divided between those betting on market resilience and a "buy the dip" rebound, and those fearing a deeper correction spurred by rising oil prices and geopolitical instability.

MongoDB, Inc. engages in the development and provision of a general-purpose database platform. The firm's products include MongoDB Enterprise Advanced, MongoDB Atlas, and Community Server. It also offers professional services including consulting and training. The company was founded by Eliot Horowitz, Dwight A. Merriman, Kevin P. Ryan, and Geir Magnusson Jr. in November 2007 and is headquartered in New York, NY.

MongoDB Inc - Ordinary Shares - Class A

MongoDB Inc

MongoDB is experiencing a significant sell-off following strong quarterly results but weaker-than-expected guidance and executive departures, leading to intense community debate over whether the market's drastic reaction is an overblown opportunity to "buy the dip" or a sign of deeper sector concerns.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending after its business update detailed strong revenue growth and new global partnerships for direct-to-device satellite connectivity, alongside confirmation of full funding for its ambitious constellation buildout. The update has ignited community discussion, with bulls emphasizing future revenue guidance and high-margin potential, while bears highlight current losses and the company's satellite deployment cadence.

Venture Global, Inc. engages in the development and construction of liquefied natural gas production, establishing us as a rapidly growing company delivering critical LNG to the world. It projects include Calcasieu, Plaquemines, CP2, CP3 and Delta projects. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is gaining significant attention following robust Q4 earnings and a favorable arbitration outcome against Shell, with community sentiment now overwhelmingly bullish as escalating Middle East tensions drive up LNG prices and position VG's extensive spot market exposure and expanding production capacity for substantial gains.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology Group Inc. is trending after reporting record 2025 revenue and significantly improved profitability, driven by a multi-billion dollar pipeline for AI infrastructure and data centers. The community is actively debating if these strong fundamentals will finally lead to a re-rating, with many bulls citing undervaluation compared to peers while skeptics question past price action and execution on ambitious projects.

Norwegian Cruise Line Holdings Ltd. engages in the provision of cruise travel services. It offers cruise experiences for travelers with itineraries in Europe, Asia, Australia, New Zealand, South America, Africa, Canada, Bermuda, Caribbean, Alaska and Hawaii. Its brands include Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises. The company was founded in 1966 and is headquartered in Miami, FL.

Norwegian Cruise Line Holdings Ltd

NCLH is currently trending following its latest earnings report, which presented a cautious outlook, coinciding with wider sector concerns over escalating fuel costs and geopolitical instability impacting travel demand, all while the community buzzes about activist investor Elliott Management's significant stake and push for substantial management and board changes.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Tyra Biosciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights

Tyra Biosciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights Tyra Biosciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights...

Tyra Biosciences Narrows Dabogratinib Focus, Teases Mid-Year NMIBC and 2H Achondroplasia Data

Tyra Biosciences (NASDAQ:TYRA) CEO Todd Harris said the company has narrowed its focus to what he described as the highest value opportunities for its selective FGFR3 inhibitor dabogratinib...

Best Growth Stocks To Consider - February 25th

Teledyne Technologies, Prologis, Hamilton Lane, Ascendis Pharma A/S, Hercules Capital, Tyra Biosciences, and Trinity Capital are the seven Growth stocks to watch today, according to MarketBeat's...

Promising Growth Stocks To Follow Today - February 24th

Prologis, Ascendis Pharma A/S, Teledyne Technologies, Hamilton Lane, Hercules Capital, Tyra Biosciences, and Trinity Capital are the seven Growth stocks to watch today, according to MarketBeat's...

Tyra Biosciences (NASDAQ:TYRA) Hits New 12-Month High - What's Next?

Tyra Biosciences (NASDAQ:TYRA) Hits New 1-Year High - Here's What Happened...

Tyra Biosciences Announces Poster Presentations at the 2026 ASCO Genitourinary (GU) Cancers Symposium

Tyra Biosciences Announces Poster Presentations at the 2026 ASCO Genitourinary (GU) Cancers Symposium Tyra Biosciences Announces Poster Presentations at the 2026 ASCO Genitourinary (GU) Cancers...

Tyra Biosciences to Participate in Upcoming Investor Conferences

Tyra Biosciences to Participate in Upcoming Investor Conferences Tyra Biosciences to Participate in Upcoming Investor Conferences PR Newswire CARLSBAD, Calif., Feb. 19, 2026 CARLSBAD, Calif., Feb...

Promising Growth Stocks To Watch Today - February 18th

Prologis, Teledyne Technologies, Ascendis Pharma A/S, Hamilton Lane, Hercules Capital, Tyra Biosciences, and Trinity Capital are the seven Growth stocks to watch today, according to MarketBeat's...

Wedbush Increases Tyra Biosciences (NASDAQ:TYRA) Price Target to $53.00

Wedbush raised their price target on Tyra Biosciences from $37.00 to $53.00 and gave the company an "outperform" rating in a report on Friday...

Tyra Biosciences (NASDAQ:TYRA) Sets New 12-Month High - Time to Buy?

Tyra Biosciences (NASDAQ:TYRA) Hits New 12-Month High - Here's What Happened...

Tyra Biosciences, Inc. is a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer. Its proprietary in-house discovery platform, SNÅP, enables the rapid and precise refinement of structural design through iterative molecular SNÅPshots that help predict genetic alterations most likely to cause acquired resistance to existing therapies. TYRA is developing a pipeline of selective inhibitors of the Fibroblast Growth Factor Receptor (FGFR) family members, which are altered in approximately 7% of all cancers. The company was founded by Daniel Bensen and Todd Harris on August 2, 2018 and is headquartered in Carlsbad, CA.

Tyra Biosciences Inc

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $MDB earnings today?

TYRA
Tyra Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest TYRA News

TYRATyra Biosciences Inc